DADE/DUPONT IVD MERGER WILL ESTABLISH $1 BIL. IVD BUSINESS -- LARGEST INDEPENDENT FIRM IN SECTOR; BAIN TO SEEK DIAGNOSIS FOR LOW PROFITABILITY
This article was originally published in The Gray Sheet
Executive Summary
Dade International's purchase of DuPont's In Vitro Diagnostics creates a $1 bil. diagnostics company and gives Dade's controlling investor, Bain Capital, a business with potential for profit growth. Dade and DuPont announced Dec. 13 that they have entered an agreement under which Dade will buy DuPont's IVD business for undisclosed terms.